Variant:
rs36079186 at chr19:41512918 in CYP2A7P1, CYP2B6

Alleles (on + chromosomal strand)
T > C
Amino Acid Translation
Met198Thr
Alternate Names:
CYP2B6*27, CYP2B6:593T>C, CYP2B6:M198T, c.593T>C, g.13781136T>C, g.20715T>C, g.209092T>C, p.Met198Thr
Haplotypes
This variant is used to determine: CYP2B6*27

Variant Annotations

PharmGKB variant annotations provide information about variant-drug pairs based on individual PubMed publications. Each annotation represents information from a single paper and the goal is to report the information that the author states, not an interpretation of the paper. The PMID for supporting PubMed publications is found in the "Evidence" field.

Information presented, including study size, allele frequencies and statistics is taken directly from the publication. However, if the author does not correct p-values in cases of multiple hypotheses, curators may apply a Bonferroni correction. Curators attempt to report study size based on the actual number of participants used for the calculation of the association statistics, so the number may vary slightly from what is reported in the abstract of the paper. OMB Race Category information is derived from the paper and mapped to standardized categories. Category definitions may be found by clicking on the "OMB Race Category" link.

There are 1 annotations for this variant. Register or sign in to see them.

Publications related to rs36079186 at chr19:41512918: 1

No Dosing Guideline available No Drug Label available No Clinical Annotation available VA No VIP available No VIP available
Predictive value of known and novel alleles of CYP2B6 for efavirenz plasma concentrations in HIV-infected individuals. Clinical pharmacology and therapeutics. 2007. Rotger M, et al. [Article:17235330@PubMed]

Cross-References

UCSC Golden Path:
chr19:41512918
dbSNP:
rs36079186

Common Searches

PharmGKB® is a registered trademark of HHS and is financially supported by NIH/NIGMS. It is managed at Stanford University (R24 GM61374).
©2001-2012 PharmGKB.